The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.‎

The result was keep. John254 00:03, 18 December 2008 (UTC)[reply]

Melville Sewell Bagley (edit | talk | history | protect | delete | links | watch | logs | views) (delete) – (View log)

No material claim of notability. Unable to find any significant coverage of the subject. Bongomatic 15:34, 14 December 2008 (UTC)[reply]

• Weak keep - Notability possibly established by inventing Hesperidina. Totnesmartin (talk) 18:43, 14 December 2008 (UTC)[reply]
• Keep First registered trademark in Argentina for Hesperidina. Most of the relevant support probably in Spanish. I will see if I can find some. Yes it is just like I thought it is there but in SpanishRichardBond (talk) 00:29, 15 December 2008 (UTC)[reply]
• Keep It does appear that much of the information about him is available in Spanish, but there is enough information in a quick Google search in English to suggest that he meets WP:N. A good article for expansion and addition of references. Geoff ^{T C} 20:05, 15 December 2008 (UTC)[reply]
• Note: This debate has been included in the list of Argentina-related deletion discussions. -- the wub "?!" 12:45, 15 December 2008 (UTC)[reply]
• Note: This debate has been included in the list of Food and drink-related deletion discussions. -- the wub "?!" 12:45, 15 December 2008 (UTC)[reply]
• Note: This debate has been included in the list of Businesspeople-related deletion discussions. -- Raven1977 (talk) 07:23, 16 December 2008 (UTC)[reply]
• Keep. He's covered by history books [1], so should be covered by Wikipedia. Phil Bridger (talk) 16:12, 16 December 2008 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.